Cargando…
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Geriatric Inpatients at a German Tertiary University Teaching Hospital: A Retrospective Observational Cohort Study of Clinical Practice
Current iron supplementation practice in geriatric patients is erratic and lacks evidence-based recommendations. Despite potential benefits in this population, intravenous iron supplementation is often withheld due to concerns regarding pharmacy expense, perceived safety issues, and doubts regarding...
Autores principales: | Bach, Matthias, Geisel, Tabea, Martin, Julia, Schulze, Bettina, Schaefer, Roland, Virgin, Garth, Stein, Juergen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506836/ https://www.ncbi.nlm.nih.gov/pubmed/26236500 http://dx.doi.org/10.1155/2015/647930 |
Ejemplares similares
-
An Etiologic Profile of Anemia in 405 Geriatric Patients
por: Geisel, Tabea, et al.
Publicado: (2014) -
Intravenous ferric carboxymaltose for anaemia in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2014) -
Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial
por: Trenkwalder, Claudia, et al.
Publicado: (2017) -
Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
por: Friedrisch, João Ricardo, et al.
Publicado: (2015) -
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
por: Fang, Wendy, et al.
Publicado: (2019)